Continuous positive airway pressure treatment associates with decreasing glycosylated hemoglobin (HbA1c) even in euglycemic obstructive sleep apnoea patients within normal HbA1c range

A. Panoutsopoulos, T. Chimonas, A. Kallianos, K. Kostopoulos, K. Arampatzi, A. Liakou, C. Kostopoulos, L. Velentza, G. Dionellis, M. Theodorakis (Athens, Argos, Greece)

Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Session: Systemic consequences of sleep-disordered breathing
Session type: E-Communication Session
Number: 2837
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Panoutsopoulos, T. Chimonas, A. Kallianos, K. Kostopoulos, K. Arampatzi, A. Liakou, C. Kostopoulos, L. Velentza, G. Dionellis, M. Theodorakis (Athens, Argos, Greece). Continuous positive airway pressure treatment associates with decreasing glycosylated hemoglobin (HbA1c) even in euglycemic obstructive sleep apnoea patients within normal HbA1c range. Eur Respir J 2009; 34: Suppl. 53, 2837

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


Positive airway pressure treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients: Longitudinal data from the ESADA
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2005; 26: Suppl. 49, 357s
Year: 2005

Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004

Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP
Source: Eur Respir J 2007; 30: 496-500
Year: 2007



Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009


Continuous positive airway pressure treatment in patients with OSA
Source: Eur Respir Mon 2010; 50: 244-266
Year: 2010


Liver function following continuous positive airway pressure therapy in obstructive sleep apnea patients
Source: International Congress 2017 – CPAP therapy
Year: 2017


Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients
Source: Eur Respir J 2009; 34: 694
Year: 2009



Serum vitamin D levels in patients with obstructive sleep apnea syndrome and concentration changes after continuous positive airway pressure treatment
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020


Titration of continuous positive airway pressure in Chinese patients with obstructive sleep apnea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Source: Sleep and Breathing Conference 2021
Year: 2021

Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Effect of automatic positive airway pressure (APAP) therapy on blood pressure (BP) in patients with obstructive sleep apnea (OSA) and hypertension
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008


Outcomes in patients with REM-related obstructive sleep apnoea (REM-OSA) treated with continuous positive airway pressure (CPAP)
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


Continuous positive airway pressure in patients with obstructive sleep apnea: Adherence dependent on apnea-hypopnea index, leakage and mask pressure
Source: Annual Congress 2011 - Epidemiology, diagnosis and treatment in obstructive sleep apnoea
Year: 2011


Continuous positive airway pressure adherence declines with age in elderly obstructive sleep apnoea patients
Source: ERJ Open Res, 5 (1) 00178-2018; 10.1183/23120541.00178-2018
Year: 2019



Effects of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea syndromes (OSAS)
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010